Purple Biotech Ltd. Annual Meeting Adjourned
Ticker: PPBT · Form: 6-K · Filed: Apr 15, 2025 · CIK: 1614744
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Purple Biotech's shareholder meeting adjourned without any business. WTF?
AI Summary
Purple Biotech Ltd. held its Annual Meeting of Shareholders on April 15, 2025, which was convened and adjourned without any business being transacted. The company, formerly known as Kitov Pharma Ltd., is a pharmaceutical preparations company based in Rehovot, Israel.
Why It Matters
The adjournment of the annual meeting without transacting business suggests a potential delay or issue in the company's governance or upcoming decisions.
Risk Assessment
Risk Level: medium — The adjournment of a shareholder meeting without conducting business can indicate underlying issues or a lack of quorum, which may pose risks to the company's operations or investor confidence.
Key Players & Entities
- Purple Biotech Ltd. (company) — Filer and subject of the report
- April 15, 2025 (date) — Date of the Annual Meeting of Shareholders
- Kitov Pharma Ltd. (company) — Former name of Purple Biotech Ltd.
FAQ
When was Purple Biotech Ltd.'s Annual Meeting of Shareholders held?
The Annual Meeting of Shareholders was held on Tuesday, April 15, 2025.
What was the outcome of the Annual Meeting of Shareholders?
The meeting was convened and adjourned without any business being transacted.
What is Purple Biotech Ltd.'s principal executive office address?
The address is 4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel.
What was Purple Biotech Ltd. formerly known as?
Purple Biotech Ltd. was formerly known as Kitov Pharma Ltd. and Kitov Pharmaceuticals Holdings Ltd.
What is Purple Biotech Ltd.'s SIC code?
The Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 15, 2025 regarding PURPLE BIOTECH LTD. (PPBT).